Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
Loading...
Second-quarter revenue totaled RMB19.74 billion. Quarterly gross margin reached 20.7%. Overseas deliveries
Extending Advanced Energy-Saving Technologies Beyond Flagship Models to a Broader Appliance Portfolio News
BANGKOK, Aug. 25, 2026 /PRNewswire/ -- Thailand's elite business leaders and outstanding enterprises have
NEW YORK, Aug. 25, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care
SUWANEE, Ga., Aug. 31, 2026 /PRNewswire/ -- Global Tier-1 supplier YFORE Technology officially commissioned its Suwanee, Georgia facility, showcasing its market-validated Anti-Pinch Sensor solutions. Leveraging near-shore manufacturing, YFORE
BANGKOK, Aug. 31, 2026 /PRNewswire/ -- Researchers from Chulalongkorn University 's Faculty of Veterinary Science have developed synthetic boar scent mimicking natural pheromones , providing a safer way to stimulate reproduction while reducing the
SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- To address the growing need for competitive talent retention among small and medium-sized enterprises (SMEs), Rewardz, a leading digital rewards and loyalty solutions provider, today announced the launch of
SUWANEE, Ga., Aug. 31, 2026 /PRNewswire/ -- Global Tier-1 automotive supplier YFORE Technology showcased its advanced Ultra-Wideband (UWB) radar sensing portfolio and expanded multi-scenario applications at its Suwanee, Georgia facility. Powered by
The QL-66B6 Executive Office Chair brings adaptive comfort to hybrid spaces for work, gaming and relaxation HONG KONG and LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- As the consumer technology industry looks toward IFA 2026 and the future of
Partnership helps gaming, wagering, hospitality, and travel operators automate identity checks, reduce manual review, and accelerate compliant self-service experiences MELBOURNE, Australia, Aug. 31, 2026 /PRNewswire/ -- AU10TIX, a global identity
Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for autologous
Third regulatory approval in less than six months enables food and beverage manufacturers to commercialize products sweetened with sweelin® in Israel. REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ -- Amai Proteins announces that the Israeli Ministry
From expert keynotes and practical workshops to a hackathon, this year's festival equips participants with practical insights to move from AI pilots to enterprise-grade deployment SINGAPORE, Aug. 31, 2026 /PRNewswire/ -- NUS-ISS has launched the
Introducing ThinQ Claw and Expanded AI Home Experiences Powered by Contextual Intelligence News Summary LG unveils the next evolution of AI Home at IFA 2026, leveraging upgraded contextual intelligence to recommend relevant actions, coordinate